The FDA granted approval to donidalorsen for adults and children aged at least 12 years to prevent hereditary angioedema ...

In 1957, just four years after Francis Crick and other scientists solved the riddle of DNA’s structure—the now famous double ...

The approval makes donidalorsen the only treatment in the US for hereditary angioedema that is an RNA-targeted prophylactic.

Yale researchers have developed a new and safe family of RNA-editing tools that utilize an RNA-targeting activity that they ...

DNA’s chemical cousin, RNA, was the messenger that carries DNA instructions from the double helix in the cell’s nucleus to ...

The ability to correct disease-causing genetic mistakes using genome editors holds great promise in medicine, but it is not without risk. When this type of "genetic surgery" is performed on DNA, for ...

In June, the monoclonal antibody garadacimab (Andembry) was approved for prevention of HAE attacks at a dose of once monthly ...

Dawnzera is the first and so far only RNA-targeting therapy approved as a prophylactic treatment for hereditary angioedema ...

RNA editing is positioned to be a breakthrough modality for multiple medicines. “We are incorporating proven components from other modalities for mechanism of action, administration ...